Stockreport

Obesity drugs won't be covered by Medicare under 2026 CMS policy [Yahoo! Finance]

Novo Nordisk A/S  (NVO) 
Last novo nordisk a/s earnings: 2/5 01:31 am Check Earnings Report
US:NYSE Investor Relations: novonordisk.com/investors.html
PDF coverage for anti-obesity drugs such as Novo Nordisk's Wegovy (semaglutide) and Eli Lilly's Zepbound (tirzepatide). First introduced in November 2024, the proposed rul [Read more]